4.2 Article

An Exceptional Broad-Spectrum Nanobiocide for Multimodal and Synergistic Inactivation of Drug-Resistant Bacteria

Journal

CCS CHEMISTRY
Volume 4, Issue 1, Pages 272-285

Publisher

CHINESE CHEMICAL SOC
DOI: 10.31635/ccschem.021.202000714

Keywords

nanobiocides; photothermal materials; in situ surface polymerization; drug-resistant bacteria; multimodal and synergistic therapy

Funding

  1. Nankai University
  2. National Natural Science Foundation of China [52003123, 21620102005, 81722026]
  3. CAMS Innovation Fund for Medical Sciences [2016-I2M-3-022]

Ask authors/readers for more resources

This study reports the fabrication of a novel photothermal material formed via physical blending and efficient ligand exchange, which shows rapid and stable photothermal responses and excellent antibacterial effects when formulated into nanoparticles.
This study reports the fabrication of a novel photothermal material formed via the physical blending of excess lauric acid (LA) and cupric acetate, followed by efficient ligand exchange. Surprisingly, the copper-LA complex exhibited a 12-fold enhancement of the molar extinction coefficient in the near-infrared (NIR) region relative to aqueous cupric acetate. Inspired by this interesting finding, we formulated these photothermal materials into colloidally dispersed nanoparticles via a technique that combined nanoprecipitation and in situ surface polymerization for antibacterial studies. The resultant nanoparticles exhibited rapid and stable photothermal responses to NIR irradiation, with a 4-fold enhanced photothermal conversion efficiency relative to aqueous cupric acetate. Since a positively charged monomer was incorporated during in situ surface polymerization, these positively charged nanoparticles were ingested efficiently and subsequently digested by drug-resistant bacteria. By combining the LA-mediated membrane-damaging effect, copper-mediated Fenton-like reaction, as well as the photothermal effect of the copper-LA complex, a broad-spectrum, multimodal, and synergistic antibacterial effect was achieved both in vitro and in vivo, with the killing efficiency up to 99.99% for ampicillin-resistant Escherichia coli (Amp' E. coli) and 99.9999% for methicillin-resistant Staphylococcus aureus (MRSA). Our newly developed nanobiocide represents a class of exceptional broad-spectrum antibacterial materials, holding great potential for treating drug-resistant infections in clinical settings. [GRAPHICS] .

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available